Clinical Trial Update: Costs & Outcomes of Hospitalization/Treatment With Levalbuterol & Albuterol in Asthma or Chronic Obstructive Pulmonary Disease (COPD) Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating costs and outcomes of hospitalization and treatment with levalbuterol and albuterol in asthma or COPD patients. The study has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Albuterol (albuterol)
• Levalbuterol (Levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma, COPD | Phase 4 | Status: COMPLETED